Elevance Health

Does Elevance Health cover Zepbound?

Quick answer · Weight Loss

Elevance Health covers Zepbound for weight loss with prior authorization on Employer / Commercial Insurance and ACA Marketplace.

  • Employer / Commercial Insurance: Covered with requirements. BMI of 30 or higher
  • ACA Marketplace: Covered with requirements. BMI of 30 or higher

Last verified June 2, 2026. Policy effective February 1, 2026. Source: Download. How we verify this data →

Check your card for your exact plan →

Zepbound for Weight Loss

What Elevance Health requires, by plan type. Open this indication on its own page →

Employer / Commercial Insurance

Covered with requirements

What you need to qualify

  • Age 18 and older
  • BMI of 30 or higher
  • BMI of 27 or higher with a weight-related condition (HTN, T2DM, dyslipidemia, OSA, and CVD)
  • 6 months of a documented diet and exercise program

Qualification pathways

You can qualify through any one of these.

Initial Approval - BMI ≥30 without comorbidity

All of:

  • Age 18 years or older
  • BMI ≥ 30 kg/m² documented within 90 days of request
  • Tried but was unsuccessful losing weight through HCP-supervised comprehensive lifestyle program for at least 6 months including calorie deficit ~30%/500 kcals/day AND ≥150 min/week exercise (or clinical exception) AND failed to achieve ≥5% weight reduction
  • Currently maintained on HCP-supervised lifestyle program with calorie deficit ~30%/500 kcals/day AND ≥150 min/week exercise (or clinical exception)
  • NOT receiving two or more medications for weight loss simultaneously
  • HCP has counseled individual regarding risks, benefits, realistic expectations, long-term follow-up, and behavior modification adherence

Initial Approval - BMI ≥27 with qualifying comorbidity

All of:

  • Age 18 years or older
  • BMI ≥ 27 kg/m² documented within 90 days of request
  • Tried but was unsuccessful losing weight through HCP-supervised comprehensive lifestyle program for at least 6 months including calorie deficit ~30%/500 kcals/day AND ≥150 min/week exercise (or clinical exception) AND failed to achieve ≥5% weight reduction
  • Currently maintained on HCP-supervised lifestyle program with calorie deficit ~30%/500 kcals/day AND ≥150 min/week exercise (or clinical exception)
  • NOT receiving two or more medications for weight loss simultaneously
  • HCP has counseled individual regarding risks, benefits, realistic expectations, long-term follow-up, and behavior modification adherence

Plus any one of:

  • Hypertension: treated hypertension OR SBP ≥130 mmHg OR DBP ≥80 mmHg
  • Type II Diabetes Mellitus
  • Dyslipidemia: treated dyslipidemia OR LDL ≥160 mg/dL OR triglycerides ≥150 mg/dL OR HDL <40 mg/dL (men) OR HDL <50 mg/dL (women)
  • Obstructive sleep apnea as a result of having a BMI of 27 or greater
  • Cardiovascular disease (e.g., ischemic cardiovascular disease, NYHA Functional Class I-III heart failure)

Continuation Approval

All of:

  • Age 18 years or older
  • Documentation that at initiation of therapy individual had BMI ≥30 kg/m² OR BMI ≥27 kg/m² with a qualifying comorbidity (hypertension, T2DM, dyslipidemia, OSA, or CVD)
  • Documentation of achieved/maintained ≥5% weight loss from initiation of therapy (required within 90 days of each continuation request)
  • Continues to be engaged in comprehensive lifestyle program: calorie deficit ~30%/500 kcals/day AND ≥150 min/week exercise (or clinical exception)
  • NOT receiving two or more medications for weight loss simultaneously
  • HCP has counseled individual regarding risks, benefits, realistic expectations, long-term follow-up, and behavior modification adherence

Documentation to bring

  • BMI documentation ≥30 kg/m² OR ≥27 kg/m² with qualifying comorbidity, measured within 90 days of the initial request
  • Documentation of qualifying weight-related comorbidity if BMI is 27–<30 (e.g., hypertension diagnosis/BP readings, T2DM diagnosis, dyslipidemia labs, OSA diagnosis, CVD diagnosis)
  • Documentation of HCP-supervised comprehensive lifestyle program of at least 6 months including calorie deficit ~30%/500 kcals/day for at least 6 months
  • Documentation of at least 150 minutes of exercise per week for at least 6 months OR documentation of clinical limitations preventing exercise
  • Documentation of failure to achieve ≥5% weight reduction with lifestyle program
  • Documentation that individual is currently maintained on HCP-supervised lifestyle program (calorie deficit and exercise or clinical exception)
  • Documentation that individual is NOT receiving two or more weight loss medications simultaneously
  • HCP attestation of risk/benefit counseling including adverse drug events, realistic expectations, long-term follow-up, and behavior modification
  • For continuation: documentation of ≥5% weight loss achieved/maintained from therapy initiation, within 90 days of each continuation request

Quantity limits

  • all strengths — May be subject to quantity limit (specific limits not detailed in document)

Approval and renewal

  • Renewal: every 6 months
  • To renew, the plan looks for at least 5% weight loss from the starting weight and Documentation of at least 5% weight loss achieved/maintained from initiation of therapy (required within 90 days of each continuation/subsequent request). Individual must continue engagement in comprehensive lifestyle program (calorie deficit ~30%/500 kcals/day and ≥150 min/week exercise or documented clinical exception). Individual must not be receiving two or more weight loss medications simultaneously. HCP must continue risk/benefit counseling. BMI criteria are verified against initiation-of-therapy documentation, not re-measured at continuation. Make sure your starting weight and date are in the chart now — renewal is measured against it.

Not covered when

  • BMI less than 18.5 kg/m²
  • Use for treatment of type 2 diabetes mellitus
  • Use in combination with another tirzepatide-containing product or any GLP-1 receptor agonist
  • Personal or family history of medullary thyroid carcinoma (MTC)
  • Diagnosis of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • History of pancreatitis
  • Severe gastrointestinal disease (including but not limited to gastroparesis)
  • History of suicide attempts or active suicidal ideation

Policy note: Initial approval duration is 32 weeks (approximately 7.5 months), not a standard round number. Continuation approvals are 6 months. The document references pediatric BMI tables (ages 12–17.5) but the approval criteria explicitly state age ≥18; the pediatric tables appear to be reference material carried over from a broader policy template and do not establish pediatric criteria for Zepbound under this document. Dyslipidemia comorbidity is defined with specific lab thresholds (LDL ≥160, TG ≥150, HDL <40 men or <50 women). OSA as a comorbidity is specifically qualified as being 'as a result of having a BMI of 27 or greater.' CVD examples include ischemic cardiovascular disease and NYHA Class I-III heart failure. The lifestyle program requirement is a formal 6-month HCP-supervised program — not merely standard diet and exercise counseling — including specific calorie deficit and exercise targets with documented outcomes.

Policy effective February 1, 2026 · verified June 2, 2026 · source: Download

ACA Marketplace

Covered with requirements

What you need to qualify

  • Age 18 and older
  • BMI of 30 or higher
  • BMI of 27 or higher with a weight-related condition (HTN, T2DM, dyslipidemia, OSA, and CVD)
  • 6 months of a documented diet and exercise program

Qualification pathways

You can qualify through any one of these.

Initial Approval - BMI ≥30 without comorbidity

All of:

  • Age 18 years or older
  • BMI ≥ 30 kg/m² documented within 90 days of request
  • Tried but was unsuccessful losing weight through HCP-supervised comprehensive lifestyle program for at least 6 months including calorie deficit ~30%/500 kcals/day AND ≥150 min/week exercise (or clinical exception) AND failed to achieve ≥5% weight reduction
  • Currently maintained on HCP-supervised lifestyle program with calorie deficit ~30%/500 kcals/day AND ≥150 min/week exercise (or clinical exception)
  • NOT receiving two or more medications for weight loss simultaneously
  • HCP has counseled individual regarding risks, benefits, realistic expectations, long-term follow-up, and behavior modification adherence

Initial Approval - BMI ≥27 with qualifying comorbidity

All of:

  • Age 18 years or older
  • BMI ≥ 27 kg/m² documented within 90 days of request
  • Tried but was unsuccessful losing weight through HCP-supervised comprehensive lifestyle program for at least 6 months including calorie deficit ~30%/500 kcals/day AND ≥150 min/week exercise (or clinical exception) AND failed to achieve ≥5% weight reduction
  • Currently maintained on HCP-supervised lifestyle program with calorie deficit ~30%/500 kcals/day AND ≥150 min/week exercise (or clinical exception)
  • NOT receiving two or more medications for weight loss simultaneously
  • HCP has counseled individual regarding risks, benefits, realistic expectations, long-term follow-up, and behavior modification adherence

Plus any one of:

  • Hypertension: treated hypertension OR SBP ≥130 mmHg OR DBP ≥80 mmHg
  • Type II Diabetes Mellitus
  • Dyslipidemia: treated dyslipidemia OR LDL ≥160 mg/dL OR triglycerides ≥150 mg/dL OR HDL <40 mg/dL (men) OR HDL <50 mg/dL (women)
  • Obstructive sleep apnea as a result of having a BMI of 27 or greater
  • Cardiovascular disease (e.g., ischemic cardiovascular disease, NYHA Functional Class I-III heart failure)

Continuation Approval

All of:

  • Age 18 years or older
  • Documentation that at initiation of therapy individual had BMI ≥30 kg/m² OR BMI ≥27 kg/m² with a qualifying comorbidity (hypertension, T2DM, dyslipidemia, OSA, or CVD)
  • Documentation of achieved/maintained ≥5% weight loss from initiation of therapy (required within 90 days of each continuation request)
  • Continues to be engaged in comprehensive lifestyle program: calorie deficit ~30%/500 kcals/day AND ≥150 min/week exercise (or clinical exception)
  • NOT receiving two or more medications for weight loss simultaneously
  • HCP has counseled individual regarding risks, benefits, realistic expectations, long-term follow-up, and behavior modification adherence

Documentation to bring

  • BMI documentation ≥30 kg/m² OR ≥27 kg/m² with qualifying comorbidity, measured within 90 days of the initial request
  • Documentation of qualifying weight-related comorbidity if BMI is 27–<30 (e.g., hypertension diagnosis/BP readings, T2DM diagnosis, dyslipidemia labs, OSA diagnosis, CVD diagnosis)
  • Documentation of HCP-supervised comprehensive lifestyle program of at least 6 months including calorie deficit ~30%/500 kcals/day for at least 6 months
  • Documentation of at least 150 minutes of exercise per week for at least 6 months OR documentation of clinical limitations preventing exercise
  • Documentation of failure to achieve ≥5% weight reduction with lifestyle program
  • Documentation that individual is currently maintained on HCP-supervised lifestyle program (calorie deficit and exercise or clinical exception)
  • Documentation that individual is NOT receiving two or more weight loss medications simultaneously
  • HCP attestation of risk/benefit counseling including adverse drug events, realistic expectations, long-term follow-up, and behavior modification
  • For continuation: documentation of ≥5% weight loss achieved/maintained from therapy initiation, within 90 days of each continuation request

Quantity limits

  • all strengths — May be subject to quantity limit (specific limits not detailed in document)

Approval and renewal

  • Renewal: every 6 months
  • To renew, the plan looks for at least 5% weight loss from the starting weight and Documentation of at least 5% weight loss achieved/maintained from initiation of therapy (required within 90 days of each continuation/subsequent request). Individual must continue engagement in comprehensive lifestyle program (calorie deficit ~30%/500 kcals/day and ≥150 min/week exercise or documented clinical exception). Individual must not be receiving two or more weight loss medications simultaneously. HCP must continue risk/benefit counseling. BMI criteria are verified against initiation-of-therapy documentation, not re-measured at continuation. Make sure your starting weight and date are in the chart now — renewal is measured against it.

Not covered when

  • BMI less than 18.5 kg/m²
  • Use for treatment of type 2 diabetes mellitus
  • Use in combination with another tirzepatide-containing product or any GLP-1 receptor agonist
  • Personal or family history of medullary thyroid carcinoma (MTC)
  • Diagnosis of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • History of pancreatitis
  • Severe gastrointestinal disease (including but not limited to gastroparesis)
  • History of suicide attempts or active suicidal ideation

Policy note: Initial approval duration is 32 weeks (approximately 7.5 months), not a standard round number. Continuation approvals are 6 months. The document references pediatric BMI tables (ages 12–17.5) but the approval criteria explicitly state age ≥18; the pediatric tables appear to be reference material carried over from a broader policy template and do not establish pediatric criteria for Zepbound under this document. Dyslipidemia comorbidity is defined with specific lab thresholds (LDL ≥160, TG ≥150, HDL <40 men or <50 women). OSA as a comorbidity is specifically qualified as being 'as a result of having a BMI of 27 or greater.' CVD examples include ischemic cardiovascular disease and NYHA Class I-III heart failure. The lifestyle program requirement is a formal 6-month HCP-supervised program — not merely standard diet and exercise counseling — including specific calorie deficit and exercise targets with documented outcomes.

Policy effective February 1, 2026 · verified June 2, 2026 · source: Download

Why Zepbound requests get denied by Elevance Health

Based on what this policy asks for. Fix these before the first submission.

  1. Wrong brand for the diagnosis. Zepbound and Mounjaro are the same molecule with different approved uses; a request for Zepbound under a diagnosis that matches Mounjaro is routinely denied.
  2. BMI not documented in the chart notes (or documented without a baseline weight and date).
  3. Qualifying weight-related condition not documented with its own diagnosis code.
  4. No documented diet and exercise program.
  5. Baseline weight wasn't recorded at the start, so the required weight loss can't be shown at renewal.

Frequently asked questions

Does Elevance Health cover Zepbound?
Elevance Health covers Zepbound for weight loss with prior authorization on Employer / Commercial Insurance and ACA Marketplace.
What BMI do you need for Zepbound under Elevance Health?
For weight loss on Employer / Commercial Insurance plans, Elevance Health requires a BMI of 30 or higher, or 27 or higher with a qualifying weight-related condition. Other plan types may differ — see each plan type below.
What does Elevance Health require to renew Zepbound?
At least 5% weight loss from the starting weight and Documentation of at least 5% weight loss achieved/maintained from initiation of therapy (required within 90 days of each continuation/subsequent request). Individual must continue engagement in comprehensive lifestyle program (calorie deficit ~30%/500 kcals/day and ≥150 min/week exercise or documented clinical exception). Individual must not be receiving two or more weight loss medications simultaneously. HCP must continue risk/benefit counseling. BMI criteria are verified against initiation-of-therapy documentation, not re-measured at continuation.
How current is this information?
This page reflects Elevance Health's written policy as of February 1, 2026, last verified against the source document on June 2, 2026.

Other medications under Elevance Health

Zepbound coverage under other plans

All insurance plans · All medications

This page summarizes Elevance Health's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.